BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 33609274)

  • 1. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms.
    Kohtala S
    Pharmacol Rep; 2021 Apr; 73(2):323-345. PubMed ID: 33609274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant.
    Lavender E; Hirasawa-Fujita M; Domino EF
    Behav Brain Res; 2020 Jul; 390():112631. PubMed ID: 32437885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
    Kim JW; Monteggia LM
    Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.
    Abdallah CG; Adams TG; Kelmendi B; Esterlis I; Sanacora G; Krystal JH
    Depress Anxiety; 2016 Aug; 33(8):689-97. PubMed ID: 27062302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
    Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
    Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine's rapid and sustained antidepressant effects are driven by distinct mechanisms.
    Rawat R; Tunc-Ozcan E; Dunlop S; Tsai YH; Li F; Bertossi R; Peng CY; Kessler JA
    Cell Mol Life Sci; 2024 Feb; 81(1):105. PubMed ID: 38413417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine: The final frontier or another depressing end?
    Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA
    Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant Effects.
    Feifel D
    Drug Dev Res; 2016 Dec; 77(8):489-494. PubMed ID: 27888525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine.
    Grieco SF; Qiao X; Johnston KG; Chen L; Nelson RR; Lai C; Holmes TC; Xu X
    Transl Psychiatry; 2021 Feb; 11(1):144. PubMed ID: 33627623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
    Kavalali ET; Monteggia LM
    Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders.
    Lewis V; Rodrigue B; Arsenault E; Zhang M; Taghavi-Abkuh FF; Silva WCC; Myers M; Matta-Camacho E; Aguilar-Valles A
    J Neurochem; 2023 Jul; 166(1):10-23. PubMed ID: 35680556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Mechanisms Underlying Antidepressant Responses of Ketamine and Imipramine.
    Wei Z; Zhang K; Zhou Q; Huang M; Xu T; Dong J; Zheng Y; Cai X
    CNS Neurol Disord Drug Targets; 2017; 16(7):846-853. PubMed ID: 28462695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between ketamine's short-term and long-term effects on brain circuitry in depression.
    Gass N; Becker R; Reinwald J; Cosa-Linan A; Sack M; Weber-Fahr W; Vollmayr B; Sartorius A
    Transl Psychiatry; 2019 Jun; 9(1):172. PubMed ID: 31253763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
    Suzuki K; Monteggia LM
    Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A key requirement for synaptic Reelin signaling in ketamine-mediated behavioral and synaptic action.
    Kim JW; Herz J; Kavalali ET; Monteggia LM
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33975959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.